Question to the Foreign, Commonwealth & Development Office:
To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent assessment his Department has made of the potential impact of UK funding for UNITAID on the cost of HPV testing in (a) low and (b) middle-income countries.
Unitaid are a leading funder of innovative tools to find and treat cervical cancer in low- and middle-income countries, with HPV tests the most accurate way to identify if a woman is at higher risk of developing cervical cancer. Together with partners, Unitaid's interventions lowered the cost of HPV testing by nearly 40 per cent and reduced the price of portable thermal ablation devices for treating precancerous lesions by more than 45 per cent. Unitaid's work is laying the groundwork for national cervical cancer elimination programs worldwide. We highly value our Unitaid partnership and have contributed more than half a billion pounds in funding.